India's unhealthy patent amendments: Despite strong pleas, the Modi regime has changed the rules to impose a cost on those who challenge faulty patents.

The Modi government in India has made amendments to the country's Patent Act, despite protests and petitions against the changes. These amendments have altered the unique law on patent rights and obligations in India, and have serious consequences for patient and voluntary groups advocating for public health concerns. The amendments aim to align India's patent law with international standards, but they have also diluted provisions that protect public health and increased fees for patient health groups. The changes have been welcomed by corporate law firms and foreign manufacturers, but they have raised concerns about access to life-saving medications and the transparency of patent holders' activities. [Extracted from the article]